| Life360 Inc (360) CDI 3:1 FOREIGN EXEMPT XNGS |
Information Technology |
$3,917 |
SEC Schedule 13G/A
|
16 Jun 2025 9:37AM |
$31.450 |
$21.760 |
fallen by
30.81%
|
|
| Blaze Minerals Limited (BLZ) ORDINARY FULLY PAID |
Energy |
$3 |
Trading Halt
|
16 Jun 2025 9:36AM |
$0.003 |
$0.001 |
fallen by
66.67%
|
|
BLZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Blaze Minerals Limited requested a trading halt on 10 October 2023.
- The trading halt is pending an announcement regarding a material acquisition.
- Trading will remain halted until either the announcement is made or until the start of trading on 12 October 2023.
- The halt is intended to ensure the market is fully informed.
- The company submitted the request to the ASX to prevent uninformed trading.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FireFly Metals Ltd (FFM) ORDINARY FULLY PAID |
Materials |
$1,668 |
FireFly Equity Raising Advances
|
16 Jun 2025 9:35AM |
$1.055 |
$2.170 |
risen by
105.69%
|
|
| Aspen Group (APZ) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,109 |
Application for quotation of securities - APZ
|
16 Jun 2025 9:35AM |
$3.650 |
$4.870 |
risen by
33.42%
|
|
| The Star Entertainment Group Limited (SGR) ORDINARY FULLY PAID |
Consumer Discretionary |
$763 |
Notification of ceasing to be a substantial holder -JPMorgan
|
16 Jun 2025 9:35AM |
$0.130 |
$0.115 |
fallen by
11.54%
|
|
| Horizon Oil Limited (HZN) ORDINARY FULLY PAID |
Energy |
$391 |
Commencement of Production from WZ12-8M Infill Well
|
16 Jun 2025 9:34AM |
$0.185 |
$0.240 |
risen by
29.73%
|
|
HZN - Price-sensitive ASX Announcement
Full Release
Key Points
- Horizon Oil Limited has commenced production from the WZ12-8M infill well in the WZ12-8E field, Block 22/12 offshore China.
- The company holds a 26.95% interest in the WZ12-8E field.
- Production from the new well started ahead of schedule.
- Initial production rates from the WZ12-8M well have exceeded expectations.
- The successful start of production will enhance field output and improve Horizon Oil’s financial performance.
- The project demonstrates strong execution and collaboration with the field operator, CNOOC.
- The announcement supports Horizon Oil’s strategy to optimize and develop its asset base.
- Horizon Oil reaffirms its commitment to delivering value to shareholders through efficient project delivery.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$294 |
Weekly Estimated NTA as at 13 June 2025
|
16 Jun 2025 9:34AM |
$1.095 |
$0.930 |
fallen by
15.07%
|
|
| Prospect Resources Limited (PSC) ORDINARY FULLY PAID |
Materials |
$260 |
Non-Executive Director Appointment
|
16 Jun 2025 9:33AM |
$0.150 |
$0.320 |
risen by
113.33%
|
|
| Boab Metals Limited (BML) ORDINARY FULLY PAID |
Materials |
$245 |
Proposed issue of securities - BML
|
16 Jun 2025 9:33AM |
$0.180 |
$0.425 |
risen by
136.11%
|
|
| Duxton Water Limited (D2O) ORDINARY FULLY PAID |
Utilities |
- |
Update - Notification of buy-back - D2O
|
16 Jun 2025 9:33AM |
$1.520 |
$1.530 |
risen by
0.66%
|
|
| HeraMED Limited (HMD) ORDINARY FULLY PAID |
Health Care |
$57 |
Grant Awarded to Advance AI Maternity Care with RMIT & DHCRC
|
16 Jun 2025 9:33AM |
$0.009 |
$0.049 |
risen by
444.44%
|
|
HMD - Price-sensitive ASX Announcement
Full Release
Key Points
- HeraMED Limited awarded AUD $1.18 million grant from DHCRC with RMIT University.
- Funding supports a two-year project to advance the HeraCARE digital maternity care platform.
- Focus is on integrating advanced AI and data from multiple hospital and community sources.
- Project aims to deliver clinical-grade AI solutions to support and predict maternal health outcomes.
- AI models will assist in personalizing the care journey, providing risk stratification, and improving resource allocation.
- Collaboration recognized as validation of HeraMED’s leadership in digital maternal health innovation.
- Grant will facilitate partnership with leading researchers, clinicians and digital health experts.
- The project seeks to reduce healthcare costs and improve maternal care quality and efficiency.
- HeraMED’s platform is expected to set new benchmarks in AI-powered digital health.
- The outcome aims to support midwives, clinicians, and expectant mothers through better digital tools.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$65 |
NUZ-001 Shows Promise in a Model of Huntington's Disease
|
16 Jun 2025 9:32AM |
$0.160 |
$0.088 |
fallen by
45%
|
|
NUZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurizon Therapeutics Limited is developing NUZ-001 as a potential treatment for Huntington's disease.
- NUZ-001 is a selective, brain-penetrant small molecule targeting a novel mechanism in HD.
- Preclinical studies in animal models demonstrated improved motor function following NUZ-001 administration.
- Treatment with NUZ-001 reduced pathological markers such as mutant huntingtin aggregates in the HD model.
- The compound showed a favorable safety profile in preclinical studies.
- Results support the further development of NUZ-001 as a therapeutic for Huntington's disease.
- Announcement of these findings was made on June 6, 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Boab Metals Limited (BML) ORDINARY FULLY PAID |
Materials |
$245 |
A$6 Million Placement to Advance the Sorby Hills Project
|
16 Jun 2025 9:32AM |
$0.180 |
$0.425 |
risen by
136.11%
|
|
BML - Price-sensitive ASX Announcement
Full Release
Key Points
- Boab Metals Limited completed a A$6 million placement to fund the Sorby Hills Project.
- The placement was well supported by institutional and sophisticated investors.
- Funds will be directed toward advancing the Sorby Hills Project to Final Investment Decision.
- Planned activities include completing the Definitive Feasibility Study and permitting.
- Sorby Hills is one of Australia's largest undeveloped, near-surface lead-silver-zinc deposits.
- The company highlights the project's robust economics and strategic significance.
- The announcement includes details of share price, placement structure, and timetable.
- Boab Metals is focused on de-risking and progressing the project to deliver shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$720 |
Weekly Estimate NTA for 13.06.2025
|
16 Jun 2025 9:31AM |
$2.850 |
$3.440 |
risen by
20.70%
|
|
| Bathurst Resources Limited (BRL) ORDINARY FULLY PAID |
Materials |
$146 |
Roadshow Presentation
|
16 Jun 2025 9:31AM |
$0.730 |
$0.610 |
fallen by
16.44%
|
|
BRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Bathurst Resources Limited is a major coal producer based in New Zealand.
- The company operates several mines, including Stockton, Maramarua, Rotowaro, and others.
- Recent production and sales figures are provided, showcasing consistent operational performance.
- BRL emphasizes safety, environmental management, and strong community relations.
- Financial highlights include summaries of revenue, profit, and cash flow.
- The presentation notes secured sales contracts with major domestic and export customers.
- Market dynamics affecting coal demand and pricing are discussed.
- Growth strategies include expansion of existing operations and new project development.
- Sustainability initiatives focus on responsible mine closure, environmental restoration, and emissions management.
- BRL maintains a strong balance sheet to support ongoing operations and future investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ainsworth Game Technology Limited (AGI) ORDINARY FULLY PAID |
Consumer Discretionary |
$387 |
Acknowledgement of Media Reports
|
16 Jun 2025 9:31AM |
$0.920 |
$1.150 |
risen by
25%
|
|
| Hawk Resources Limited (HWK) ORDINARY FULLY PAID |
Materials |
$17 |
Change in substantial holding
|
16 Jun 2025 9:30AM |
$0.015 |
$0.033 |
risen by
120%
|
|
| Bryah Resources Limited (BYH) ORDINARY FULLY PAID |
Materials |
$6 |
Golden Pike Option Extension
|
16 Jun 2025 9:29AM |
$0.012 |
$0.004 |
fallen by
66.67%
|
|
| Butn Limited (BTN) ORDINARY FULLY PAID |
Financials |
$11 |
Proposed issue of securities - BTN
|
16 Jun 2025 9:29AM |
$0.105 |
$0.029 |
fallen by
72.38%
|
|
| Butn Limited (BTN) ORDINARY FULLY PAID |
Financials |
$11 |
Butn Positions for Growth with A$20m Additional Funding
|
16 Jun 2025 9:29AM |
$0.105 |
$0.029 |
fallen by
72.38%
|
|
BTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Butn Limited secures $20 million in additional funding from Goldman Sachs.
- Total funding facilities now total approximately $150 million.
- New capital will support increased working capital funding and growth opportunities.
- Butn’s technology platform and digital origination model support scalable growth.
- The additional funding reflects confidence in Butn’s business model, technology, and growth trajectory.
- Butn provides fast, flexible funding solutions to Australian SMEs.
- The company highlights operational efficiencies and strategic partnerships.
- Butn sees a strong and growing pipeline of opportunities.
- Leadership expresses enthusiasm about supporting more businesses and executing on growth strategies.
- Funding facility is set under materially similar terms to existing arrangements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$1,541 |
Update - Notification of buy-back - NEU
|
16 Jun 2025 9:28AM |
$13.100 |
$12.180 |
fallen by
7.02%
|
|
| 3D Energi Limited (TDO) ORDINARY FULLY PAID |
Energy |
$42 |
Otway Basin Exploration Well Locations
|
16 Jun 2025 9:27AM |
$0.110 |
$0.080 |
fallen by
27.27%
|
|
| Black Canyon Limited (BCA) ORDINARY FULLY PAID |
Materials |
$58 |
Proposed issue of securities - BCA
|
16 Jun 2025 9:26AM |
$0.089 |
$0.360 |
risen by
304.49%
|
|
| Lithium Universe Limited (LU7) ORDINARY FULLY PAID |
Materials |
$16 |
Trading Halt
|
16 Jun 2025 9:26AM |
$0.006 |
$0.010 |
risen by
66.67%
|
|
LU7 - Price-sensitive ASX Announcement
Full Release
Key Points
- Lithium Universe Limited (LU7) requested a trading halt on 21 June 2024.
- The trading halt was requested pending an announcement regarding a capital raising.
- ASX has granted the trading halt, effective immediately, and it will remain in place until the earlier of the commencement of normal trading on 25 June 2024 or when the announcement is released to the market.
- The company confirmed it is not aware of any reason why the trading halt should not be granted.
- All trading in the company’s securities has been paused to allow for a fair and informed market upon the release of the pending announcement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pacific Edge Limited (PEB) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$153 |
Letter to Shareholders
|
16 Jun 2025 9:26AM |
$0.105 |
$0.150 |
risen by
42.86%
|
|
PEB - Price-sensitive ASX Announcement
Full Release
Key Points
- PEB's Cxbladder tests will lose Medicare coverage in the US due to the final LCD from Novitas.
- A strategic review is underway to explore options like asset sales, partnerships, or restructuring.
- The company is implementing cost-saving measures and reviewing its global operations.
- Leadership acknowledges the difficult environment and thanks shareholders for their ongoing support.
- PEB continues commercial operations in New Zealand and Australia.
- Financial impacts and the uncertainties around future US revenues are highlighted.
- The Board remains focused on preserving shareholder value through the review process.
- Shareholders are encouraged to stay engaged as the company navigates these changes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
